Project Grant R43DC021398
Award Date
7/2/24
Completion Date
6/30/25
Dollars Obligated
$305K
Federal Grant Program
93.173
Assistance Type
Project Grant
Place of Performance
San Francisco, CA 94107, USA
Similar Awards
The National Institute on Deafness and Other Communication Disorders (NIDCD) awarded a $1,022,655 Project Grant under the Research Related to Deafness and Communication Disorders (CFDA 93.173) program to Turner Scientific LLC, a small disadvantaged business. The grant supports the development of a minipig model to evaluate drug pharmacokinetics and implantable device development for inner ear research. The project aims to provide the hearing research community with a large animal model to...
This federal Project Grant award for $581,105, awarded by the National Institute on Deafness and Other Communication Disorders (NIDCD) under the Research Related to Deafness and Communication Disorders program (CFDA 93.173), supports research to develop natural-based therapies for sensory disorders, with a focus on aminoglycoside-induced hearing loss. The award funds research by Creighton University to: 1) design and synthesize piperlongumine derivative compounds to better target the TRPV1...
The University of Miami was awarded a $767,494 five-year Project Grant (R01DC022239) from the National Institute on Deafness and Other Communication Disorders (CFDA 93.173) to develop human induced pluripotent stem cell-derived inner ear organoid platforms for testing gene therapies and treatments for genetic hearing and balance disorders. The project aims to establish human inner ear organoid models to evaluate the cellular consequences of CRISPR/Cas9-based gene editing strategies for...
This federal Project Grant award from the National Institute on Deafness and Other Communication Disorders (NIDCD), under the Research Related to Deafness and Communication Disorders program (CFDA 93.173), provides $275,737 to Rewire Neuroscience LLC to develop and validate a machine learning platform for predicting the ototoxic potential of pharmaceutical compounds. The key objectives are to: 1) optimize and apply an innovative machine learning model that can categorize drugs as ototoxic or...
This $659,164 Project Grant awarded by the National Institute on Deafness and Other Communication Disorders (NIDCD), under the Research Related to Deafness and Communication Disorders program (CFDA 93.173), aims to identify pharmacological modulators, endogenous ligands, and binding partners for the orphan G protein-coupled receptor GPR156. The grant, awarded to the University of Rochester, will leverage innovative cell-based assays and proximity-mediated labeling technologies to discover new...
The National Institute on Deafness and Other Communication Disorders (NIDCD) awarded The Leland Stanford Junior University a $713,170 Project Grant under the Research Related to Deafness and Communication Disorders program (CFDA 93.173). The grant supports the development and validation of a Multimodality Micro-Optical Coherence Tomography (MM-MOCT) imaging technology to visualize the microscopic cellular structure and metabolic activity of the human inner ear. This new capability aims to...
This Project Grant award from the National Institute on Deafness and Other Communication Disorders (NIDCD), under the federal Research Related to Deafness and Communication Disorders Program (CFDA 93.173), aims to develop a new method for enhanced delivery of therapeutics to treat and prevent hearing loss. The $498,000 award to the University of Pittsburgh will fund research to: 1) Validate an ex-vivo porcine round window membrane (RWM) model to demonstrate drug permeability equivalent to...
The National Institute on Deafness and Other Communication Disorders (NIDCD) awarded a $275,371 Project Grant (CFDA 93.173) to Auricle Health Inc. to develop an extracochlear device to restore hearing for patients with sensorineural hearing loss (SNHL). The funding will support refinement of the electrode design, demonstration of electrical stimulation of the cochlear nerve in animal models, and evaluation of the long-term safety and durability of the implant. This project aims to create a...
This Project Grant award from the National Institute on Deafness and Other Communication Disorders (NIDCD), part of the Research Related to Deafness and Communication Disorders federal grant program (CFDA 93.173), provides $305,628 to Echogenesis Therapeutics Inc. to develop a cell-type-specific gene therapy approach for treating TOMT-linked congenital hearing loss. The project aims to 1) determine effective dosages for hearing restoration, 2) identify the optimal timing window for therapeutic...
The U.S. National Institute on Deafness and Other Communication Disorders (NIDCD) awarded a 5-year, $673,048 Project Grant (CFDA 93.173) to Case Western Reserve University to investigate the role of mitochondrial calcium regulation in acquired hearing loss. The research aims to determine the effects of acoustic overstimulation on cochlear hair cell function and morphology, and evaluate whether preventing mitochondrial calcium overload can protect against hearing deficits in mouse models. A...